Agostinho, P., Pliássova, A., Oliveira, C. R., & Cunha, R. A. (2015). Localization and trafficking of amyloid-β protein precursor and secretases: Impact on Alzheimer’s disease. Journal of Alzheimer’s Disease, 45, 329–347.
Bierman, E. J., Comijs, H. C., Jonker, C., & Beekman, A. T. (2007). Symptoms of anxiety and depression in the course of cognitive decline. Dementia and Geriatric Cognitive Disorders, 24, 213–219.
Cai, X., Chiu, Y. H., & Chen, Z. J. (2014). The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Molecular Cell, 54(2), 289–296.
Calsolaro, V., & Edison, P. (2016). Neuroinflammation in Alzheimer’s disease: Current evidence and future directions. Alzheimer’s and Dementia, 12(6), 719–732.
Choi, S. S., Han, E. J., Lee, T. H., Lee, J. K., Han, K. J., Lee, H. K., & Suh, H. W. (2002). Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse. Planta Medica, 68(9), 794–798.
Choi, J. H., Yoo, K. Y., Park, O. K., Lee, C. H., Won, M. H., Hwang, I. K., Ryu, S. Y., Kim, Y. S., Yi, J. S., Bae, Y. S., & Kang, I. J. (2009). Platycodin D and 2″-O-acetyl-polygalacin D2 isolated from Platycodin D grandiflorum protect ischemia/reperfusion injury in the gerbil hippocampus. Brain Research, 1279, 197–208.
D’Hooge, R., & De Deyn, P. P. (2001). Applications of the Morris water maze in the study of learning and memory. Brain Research. Brain Research Reviews, 36, 60–90.
Donovan, N. J., Locascio, J. J., Marshall, G. A., Gatchel, J., Hanseeuw, B. J., Rentz, D. M., Johnson, K. A., & Sperling, R. A. (2018). Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. The American Journal of Psychiatry, 175, 530–537.
Fo¨rstl, H., & Kurz, A. (1999). Clinical features of Alzheimer’s disease. European Archives of Psychiatry and Clinical Neuroscience, 249, 288–290.
Gao, S., Zhang, X., Song, Q., Liu, J., Ji, X., & Wang, P. (2019). POLD1 deficiency is involved in cognitive function impairment in AD patients and SAMP8 mice. Biomedicine and Pharmacotherapy, 114, 108833.
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006). Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiology and Disease, 24, 516–524.
Govindarajulu, M., Ramesh, S., Beasley, M., Lynn, G., Wallace, C., Labeau, S., Pathak, S., Nadar, R., Moore, T., & Dhanasekaran, M. (2023). Role of cGAS-Sting signaling in Alzheimer’s disease. International Journal of Molecular Sciences, 24(9), 8151.
Graff-Radford, J., Yong, K. X. X., Apostolova, L. G., Bouwman, F. H., Carrillo, M., Dickerson, B. C., Rabinovici, G. D., Schott, J. M., Jones, D. T., & Murray, M. E. (2021). New insights into atypical Alzheimer’s disease in the era of biomarkers. The Lancet Neurology, 20(3), 222–234.
Hall, C. S. (1934). Emotional behavior in the rat i. Defecation and urination as measures of individual differences in emotionality. Journal of Comparative Psychology, 18, 385–403.
Hoekstra, J. G., Hipp, M. J., Montine, T. J., & Kennedy, S. R. (2016). Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage. Annals of Neurology, 80(2), 301–306.
Komada, M., Takao, K., & Miyakawa, T. (2008). Elevated plus maze for mice. Journal of Visualized Experiments, 22, 1088.
Kraeuter, A. K., Guest, P. C., & Sarnyai, Z. (2019). The open field test for measuring locomotor activity and anxiety-like behavior. Methods in Molecular Biology, 1916, 99–103.
Lane, C. A., Hardy, J., & Schott, J. M. (2018). Alzheimer’s disease. European Journal of Neurology, 25, 59–70.
Lester, A. W., Moffat, S. D., Wiener, J. M., Barnes, C. A., & Wolbers, T. (2017). The aging navigational system. Neuron, 95, 1019–1035.
Li, M., Meng, Y., Chu, B., Shen, Y., Liu, X., Ding, M., Song, C., Cao, X., Wang, P., Xu, L., Wang, Y., Xu, S., Bi, J., & Xie, Z. (2020). Orexin-A aggravates cytotoxicity and mitochondrial impairment in SH-SY5Y cells transfected with APPswe via p38 MAPK pathway. Annals of Translational Medicine, 8(1), 5.
Lu, Y. W., Xie, L. Y., Qi, M. H., Ren, S., Wang, Y. Q., & Hu, J. N. (2024). Platycodin D ameliorates cognitive impairment in type 2 diabetes mellitus mice via regulating PI3K/Akt/GSK3β signaling pathway. Journal of Agricultural and Food Chemistry, 72(22), 12516–12528.
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023). Mitochondrial control of inflammation. Nature Reviews Immunology, 23(3), 159–173.
Masters, C. L., & Beyreuther, K. (2006). Pathways to the discovery of the Abeta amyloid of Alzheimer’s disease. Journal of Alzheimer’s Disease, 9, 155–161.
Meyerolbersleben, L., Winter, C., & Bernhardt, N. (2020). Dissociation of wanting and liking in the sucrose preference test in dopamine transporter overexpressing rats. Behavioural Brain Research, 378, 112244.
Modrego, P. J. (2010). Depression in Alzheimer’s disease. Pathophysiology, diagnosis, and treatment. Journal of Alzheimer’s Disease, 21, 1077–1087.
Modrego, P. J., & Ferrández, J. (2004). Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: A prospective cohort study. Archives of Neurology, 61, 1290–1293.
Muke, I., Sprenger, A., Bobylev, I., Wiemer, V., Barham, M., Neiss, W. F., & Lehmann, H. C. (2020). Ultrastructural characterization of mitochondrial damage in experimental autoimmune neuritis. Journal of Neuroimmunology, 343, 577218.
Pentkowski, N. S., Berkowitz, L. E., Thompson, S. M., Drake, E. N., Olguin, C. R., & Clark, B. J. (2018). Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer’s disease. Neurobiology of Aging, 61, 169–176.
Qu, Y., Zhou, L., & Wang, C. (2016). Effects of platycodin D on IL-1β-induced inflammatory response in human osteoarthritis chondrocytes. International Immunopharmacology, 40, 474–479.
Reddy, P. H., Yin, X., Manczak, M., Kumar, S., Pradeepkiran, J. A., Vijayan, M., & Reddy, A. P. (2018). Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease. Human Molecular Genetics, 27(14), 2502–2516.
Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021). Mitochondrial dysfunction as a driver of cognitive impairment in Alzheimer’s disease. International Journal of Molecular Sciences, 22, 4850.
Shi, C., Li, Q., & Zhang, X. (2020). Platycodin D protects human fibroblast cells from premature senescence induced by H2O2 through improving mitochondrial biogenesis. Pharmacology, 105(9–10), 598–608.
Sinoff, G., & Werner, P. (2003). Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline. International Journal of Geriatric Psychiatry, 18, 951–959.
Stępnik, K. (2021). Biomimetic chromatographic studies combined with the computational approach to investigate the ability of triterpenoid saponins of plant origin to cross the blood-brain barrier. International Journal of Molecular Sciences, 22(7), 3573.
Stukalin, Y., Lan, A., & Einat, H. (2020). Revisiting the validity of the mouse tail suspension test: Systematic review and meta-analysis of the effects of prototypic antidepressants. Neuroscience and Biobehavioral Reviews, 112, 39–47.
Sun, C., Qiu, X., Wang, Y., Liu, J., Li, Q., Jiang, H., Li, S., & Song, C. (2020). Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice. Neuroscience Letters, 735, 135192.
Udeochu, J. C., Amin, S., Huang, Y., Fan, L., Torres, E. R., Carling, G. K., Liu, B., McGurran, H., Coronas-Samano, G., Kauwe, G., & Mousa, G. A. (2023). Tau activation of microglial cGAS–IFN reduces MEF2C-mediated cognitive resilience. Nature Neuroscience, 26(5), 737–750.
Várkonyi, D., Török, B., Sipos, E., Fazekas, C. L., Bánrévi, K., Correia, P., Chaves, T., Farkas, S., Szabó, A., Martínez-Bellver, S., Hangya, B., & Zelena, D. (2022). Investigation of anxiety- and depressive-like symptoms in 4- and 8-month-old male triple transgenic mouse models of Alzheimer’s disease. International Journal of Molecular Sciences, 23, 10816.
Visser, P. J., Verhey, F. R., Ponds, R. W., Kester, A., & Jolles, J. (2020). Distinction between preclinical Alzheimer’s disease and depression. Journal of the American Geriatrics Society, 48, 479–484.
Wang, Z. X., Tan, L., Liu, J., & Yu, J. T. (2016). The essential role of soluble Aβ oligomers in Alzheimer’s disease. Molecular Neurobiology, 53, 1905–1924.
Wang, C., Lin, H., Yang, N., Wang, H., Zhao, Y., Li, P., Liu, J., & Wang, F. (2019). Effects of platycodins folium on depression in mice based on a UPLC-Q/TOF-MS serum assay and hippocampus metabolomics. Molecules, 24(9), Article 1712.
Wang, G., Guo, H., & Wang, X. (2019). Platycodin d protects cortical neurons against oxygen-glucose deprivation/reperfusion in neonatal hypoxic-ischemic encephalopathy. Journal of Cellular Biochemistry, 120, 14028–14034.
Wang, S., Liao, Z., Zhang, Q., Han, X., Liu, C., & Wang, J. (2025). Mitochondrial dysfunction in Alzheimer’s disease: A key frontier for future targeted therapies. Frontiers in Immunology, 15, 1484373.
Wang, W., Zhao, F., Ma, X., Perry, G., Zhu, X. (2020). Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Mol Neurodegener, 15(1):30.
Wu, C., Yang, L., Li, Y., Dong, Y. A., Yang, B., Tucker, L. D., Zong, X., & Zhang, Q. (2020). Effects of exercise training on anxious–depressive-like behavior in Alzheimer rat. Medicine and Science in Sports and Exercise, 52(7), 1456–1469.
Xie, X., Ma, G., Li, X., Zhao, J., Zhao, Z., & Zeng, J. (2023). Activation of innate immune cGAS-STING pathway contributes to Alzheimer’s pathogenesis in 5×FAD mice. Nature Aging, 3(2), 202–212.
Xue, L. L., Huangfu, L. R., Du, R. L., Chen, L., Yu, C. Y., Xiong, L. L., & Wang, T. H. (2022). The age-specific pathological changes of β-amyloid plaques in the cortex and hippocampus of APP/PS1 transgenic AD mice. Neurological Research, 44, 1053–1065.
Yang, X., Yu, B., Xi, C., Song, C., Yang, R., Wang, W., Wang, X., Zhang, X., Feng, C., Wang, X., Cheng, G., Chen, Y., & Zhu, Y. (2023). A safety study on ultra-high or moderate static magnetic fields combined with platycodin D against lung cancer. Oncology Letters, 26(4), 453.
Comments (0)